OBJECTIVE: To investigate the toxicity of an ethanolic extract of the aerial parts of Tithonia diversifolia, used in Nigeria to treat malaria, in rats. MATERIALS AND METHODS: A 70% ethanol extract was administered orally to adult Wistar rats at various dosages (400-1600 mg/kg) and the animals sacrificed and various organs examined at a range of times from 30 min up to 24 h after administration. RESULTS: The studies showed a dose- and time-dependent toxic effect, which was reversible on the kidney and liver while there was no noticeable adverse effect on the morphology of the heart, spleen and brain. CONCLUSION: A 70% ethanol extract of the aerial parts of Tithonia diversifolia, which had previously been shown to reduce parasitemia in mice infected with Plasmodium, displayed kidney and liver toxicity at the lowest dose tested. The use of this plant extract against malaria therefore raises concerns over its safety.
OBJECTIVE: To investigate the toxicity of an ethanolic extract of the aerial parts of Tithonia diversifolia, used in Nigeria to treat malaria, in rats. MATERIALS AND METHODS: A 70% ethanol extract was administered orally to adult Wistar rats at various dosages (400-1600 mg/kg) and the animals sacrificed and various organs examined at a range of times from 30 min up to 24 h after administration. RESULTS: The studies showed a dose- and time-dependent toxic effect, which was reversible on the kidney and liver while there was no noticeable adverse effect on the morphology of the heart, spleen and brain. CONCLUSION: A 70% ethanol extract of the aerial parts of Tithonia diversifolia, which had previously been shown to reduce parasitemia in mice infected with Plasmodium, displayed kidney and liver toxicity at the lowest dose tested. The use of this plant extract against malaria therefore raises concerns over its safety.
Authors: Tivadar Kiss; Andrea Szabó; Gábor Oszlánczi; Anita Lukács; Zoltán Tímár; László Tiszlavicz; Dezső Csupor Journal: PLoS One Date: 2017-05-04 Impact factor: 3.240
Authors: Aline M R Silva; Nayara L O Ferreira; Anselmo E Oliveira; Leonardo L Borges; Edemilson C Conceição Journal: Pharmacogn Mag Date: 2017-04-18 Impact factor: 1.085
Authors: Elizabeth A Odongo; Peggoty C Mutai; Beatrice K Amugune; Nelly N Mungai Journal: Evid Based Complement Alternat Med Date: 2022-03-24 Impact factor: 2.629
Authors: Aitebiremen Gift Omokhua; Muna Ali Abdalla; Johannes Van Staden; Lyndy Joy McGaw Journal: BMC Complement Altern Med Date: 2018-10-03 Impact factor: 3.659